BridgeBio Oncology Therapeutics Inc. (BBOT) quarterly cash flow statement — complete operating, investing & financing history
BridgeBio Oncology Therapeutics Inc. (BBOT) cash flow statement — 5-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|
| Cash from Operations | -44.36M | -35.92M | -42.23M | -70.63M | -23.29M | -734.64K | -87.86K | -39.34M | -29.1K | -8.87M | 0 |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -90.45% | -4789.05% | -47970.2% | -79.51% | -79947.42% | 91.71% | - | - | - | - | - |
| Net Income | -56.45M | -42.11M | -38.8M | -44.76M | -28.43M | -487.39K | 1.95M | -17.32M | 2.21M | -15.44M | -41.69K |
| Depreciation & Amortization | 76K | 186K | 194K | 416K | 181K | 0 | 0 | 156K | 0 | 52K | 0 |
| Stock-Based Compensation | 7.23M | 0 | 2.95M | 0 | 875K | 57.92K | 77.4K | 0 | 77.4K | 1.57M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -4.8M | 3.8M | -89K | -36.7M | -389K | -325.41K | -2.25M | -33.72M | -2.44M | -1.25M | 41.69K |
| Working Capital Changes | 9.59M | 2.21M | -6.49M | 10.42M | 4.47M | 20.24K | 127.45K | 11.54M | 123.24K | 4.96M | 0 |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -5.33M | 10.69M | -2.42M | 0 | -2.05M | 0 | 104.71K | 0 | 0 | -288K | 0 |
| Cash from Investing | 45.73M | -285.41M | 7.77M | 65.56M | 9.64M | 0 | 0 | 37.91M | 0 | 2.39M | 0 |
| Capital Expenditures | -47K | -24K | -73K | -533K | -231K | 0 | 0 | -39K | 0 | -14K | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.41M | 0 | 2.41M | 0 |
| Cash from Financing | 37K | 295K | -586K | 383.99M | 18.96M | 0 | 0 | 19.78M | 0 | 6.65M | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 373.46M | 0 | 0 | 209.85K | 209.85K | 0 | -209.85K | 0 |
| Equity Issued (Net) | 37K | 416K | 0 | 22.22M | 22.22M | 0 | -187.25M | 18.5M | 0 | 6.65M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -121K | -586K | -11.69M | -3.27M | 0 | 187.04M | 1.06M | 0 | 209.85K | 0 |
| Net Change in Cash | 1.41M | -321.03M | -35.05M | 408.08M | 5.3M | -734.64K | -87.86K | -28.86K | -29.1K | 174K | 0 |
| Free Cash Flow | -44.41M | -35.94M | -42.31M | -71.16M | -23.52M | -734.64K | -87.86K | -39.38M | -29.1K | -8.88M | 0 |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -88.78% | -4792.31% | -48053.29% | -80.68% | -80741.27% | 91.73% | - | - | - | - | - |
| FCF per Share | -554.73 | -1.15 | -1.36 | -3.03 | -1.00 | -0.03 | -0.01 | -1.68 | -0.00 | -0.40 | - |
| FCF Conversion (FCF/Net Income) | 0.79x | 0.85x | 1.09x | 1.58x | 0.82x | 0.03x | 0.00x | 2.27x | 0.00x | 0.57x | - |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |